Possible interactions between neurotensin and prostaglandins in the isolated rat portal vein.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D005260:Female; D006854:Hydrocortisone / Q000494:pharmacology; D066298:In Vitro Techniques; D009119:Muscle Contraction / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects*; D009496:Neurotensin / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D011169:Portal Vein / Q000187:drug effects; D011453:Prostaglandins / Q000494:pharmacology*; D051381:Rats
D000893:Anti-Inflammatory Agents; D011453:Prostaglandins; D000804:Angiotensin II; D009496:Neurotensin; D006854:Hydrocortisone; D009638:Norepinephrine